Eric Clayman

Eric Clayman practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Eric Clayman's NPI, 1275030488, was assigned on April 12, 2018. Eric Clayman holds Massachusetts license 1020335.

Eric Clayman's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Eric Clayman also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Eric Clayman's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Eric Clayman is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Eric Clayman to 2 more medical groups, 1 breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eric Clayman practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Eric Clayman's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Eric Clayman is licensed in Massachusetts.

CMS counts 33 Medicare patients who saw Eric Clayman in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eric Clayman's median patient age at 59, with 71% women.

In 2023, Eric Clayman wrote 57 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $514 in total drug cost. In 2022, CMS named 114 claims across 4 drugs.

Eric Clayman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Eric Clayman, published from 2015 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Cell Proliferation and Mammaplasty. Eric Clayman has published most often in Eplasty. Eric Clayman's most frequent co-authors are Paul D. Smith, MD, Vincenzo Villani, MD and Zackery Jordan Beauchamp, MD.

CMS Open Payments shows 79 general payments to Eric Clayman from 18 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 75% of the total. Integra LifeSciences Corporation paid the most, $2,772.